Back to Results
First PageMeta Content
Merck / Pharmaceutics / IFPMA / Clinical research / Clinical trial / Astellas Pharma / Merck Serono / Serono / Merck KGaA / Pharmaceutical sciences / Pharmaceutical industry / Pharmacology


New leaders appointed at the International Federation of Pharmaceutical Manufacturers & Associations Masafumi Nogimori and Stefan Oschmann become IFPMA Acting President and Acting Vice President respectively Geneva, 14
Add to Reading List

Document Date: 2013-06-30 20:56:30


Open Document

File Size: 182,20 KB

Share Result on Facebook

City

Tokyo / Geneva / /

Company

Eli Lilly and Company / IFPMA Acting / IFPMA Developing World Health Partnerships / Merck Serono / Merck KGaA / AstraZeneca / Astellas Pharma Inc. / /

/

Event

Name Change / /

/

IndustryTerm

healthcare community / pharmaceuticals / research-based pharmaceutical industry / research-based pharmaceutical / health community find solutions / /

Organization

IFPMA Assembly / United Nations / International Federation of Pharmaceutical Manufacturers / International Federation of Pharmaceutical Manufacturers & Associations / /

Person

Masafumi Nogimori / John Lechleiter / David Brennan / Stefan Oschmann / Peter Shelby / /

/

Position

CEO / Board Member and Chief Executive Officer / Chairman / President / Vice President / Chairman / President and CEO / Executive / President and Acting Vice President / /

URL

www.ifpma.org / /

SocialTag